# ZBH — Zimmer Biomet · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** ZBH  
**Sources:** 20  
**Published:** 2026-10-04  
**Canonical:** https://app.k3vl4r.com/research/deep-research-zbh-zimmer-biomet-catalysts-narrative-risks-6063

---

## Snapshot (as of early October 2026)

As of the most recent close on October 2, 2026, ZBH traded at approximately USD 88.29 on the NYSE, about 17.4% below its 52-week high of USD 106.88 and near the low end of its USD 79.12–106.88 range, with a market capitalization near USD 17.1 billion [[2]](https://www.ad-hoc-news.de/boerse/news/corporate-news/zimmer-biomet-stock-trades-at-usd-88-29-as-rbc-keeps-target/70221521). (Note that some data providers quote slightly different levels—e.g., ~USD 89.69 [[4]](https://finance.yahoo.com/markets/stocks/articles/zimmer-biomet-holdings-zbh-pushes-160930511.html) and USD 91.50 [[8]](https://www.msn.com/en-us/money/other/zimmer-biomet-zbh-buy-sell-or-hold-post-q2-earnings/ar-AA2cXOKv) [[9]](https://www.msn.com/en-us/news/other/zimmer-biomet-zbh-buy-sell-or-hold-post-q2-earnings/ar-AA2cXOKv)—so the precise current price is provider-dependent.)

## Recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-zbh-zimmer-biomet-catalysts-narrative-risks-6063 (free to sign up)._
